Location: Princeton, NJ
CIK: 0000315157 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 2, 2022
Total Value: $2.258B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON (JNJ) | 12,518,000 | $2.141B | 94.8% | $171.07 * | $59.66 | +155.1% | Common | 478160104 |
| OBDC | OWL ROCK CAPITAL CORP | 4,123,202 | $58.38M | 2.6% | $14.16 * | $7.01 | +29.1% | Common | 69121K104 |
| RPRX | ROYALTY PHARMA PLC | 970,151 | $38.66M | 1.7% | $39.85 | $49.50 | -19.5% | Common | G7709Q104 |
| KCCA | KRANESHARES California Global | 495,826 | $14M | 0.6% | $28.24 | $27.03 | +4.5% | ETF | 500767553 |
| KRBN | KRANESHARES Global Carbon | 110,000 | $5.599M | 0.2% | $50.90 | $37.71 | +35.0% | ETF | 500767678 |